annual EBIT:
$529.80M+$335.36M(+172.48%)Summary
- As of today (September 13, 2025), BMRN annual earnings before interest & taxes is $529.80 million, with the most recent change of +$335.36 million (+172.48%) on December 31, 2024.
- During the last 3 years, BMRN annual EBIT has risen by +$601.14 million (+842.66%).
- BMRN annual EBIT is now at all-time high.
Performance
BMRN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$301.51M+$70.60M(+30.57%)Summary
- As of today (September 13, 2025), BMRN quarterly earnings before interest & taxes is $301.51 million, with the most recent change of +$70.60 million (+30.57%) on June 30, 2025.
- Over the past year, BMRN quarterly EBIT has increased by +$198.05 million (+191.43%).
- BMRN quarterly EBIT is now at all-time high.
Performance
BMRN quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$824.59M+$198.05M(+31.61%)Summary
- As of today (September 13, 2025), BMRN TTM earnings before interest & taxes is $824.59 million, with the most recent change of +$198.05 million (+31.61%) on June 30, 2025.
- Over the past year, BMRN TTM EBIT has increased by +$565.05 million (+217.72%).
- BMRN TTM EBIT is now at all-time high.
Performance
BMRN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BMRN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +172.5% | +191.4% | +217.7% |
| 3 y3 years | +842.7% | +873.5% | +1396.5% |
| 5 y5 years | +565.5% | +706.1% | +2470.5% |
BMRN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +842.7% | at high | +1209.5% | at high | +1396.5% |
| 5 y | 5-year | at high | +565.5% | at high | +539.5% | at high | +793.9% |
| alltime | all time | at high | +264.2% | at high | +366.7% | at high | +342.2% |
BMRN EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $301.51M(+30.6%) | $824.59M(+31.6%) |
| Mar 2025 | - | $230.91M(+67.2%) | $626.54M(+31.8%) |
| Dec 2024 | $529.80M(+172.5%) | $138.12M(-10.3%) | $475.21M(+21.6%) |
| Sep 2024 | - | $154.05M(+48.9%) | $390.76M(+50.6%) |
| Jun 2024 | - | $103.46M(+30.0%) | $259.54M(+21.9%) |
| Mar 2024 | - | $79.58M(+48.3%) | $212.85M(+9.9%) |
| Dec 2023 | $194.44M(+1804.4%) | $53.66M(+135.1%) | $193.73M(+71.6%) |
| Sep 2023 | - | $22.83M(-59.8%) | $112.89M(+59.8%) |
| Jun 2023 | - | $56.77M(-6.1%) | $70.66M(+57.5%) |
| Mar 2023 | - | $60.47M(-322.5%) | $44.85M(+337.9%) |
| Dec 2022 | $10.21M(-114.3%) | -$27.18M(+40.0%) | $10.24M(-132.8%) |
| Sep 2022 | - | -$19.41M(-162.7%) | -$31.18M(-51.0%) |
| Jun 2022 | - | $30.97M(+19.8%) | -$63.60M(-15.3%) |
| Mar 2022 | - | $25.85M(-137.7%) | -$75.11M(+0.1%) |
| Dec 2021 | -$71.34M(-32.0%) | -$68.60M(+32.4%) | -$75.06M(+94.0%) |
| Sep 2021 | - | -$51.82M(-366.3%) | -$38.70M(-22.0%) |
| Jun 2021 | - | $19.46M(-24.9%) | -$49.63M(-58.2%) |
| Mar 2021 | - | $25.90M(-180.4%) | -$118.83M(+10.3%) |
| Dec 2020 | -$104.87M(-7.9%) | -$32.24M(-48.6%) | -$107.74M(+9.0%) |
| Sep 2020 | - | -$62.75M(+26.1%) | -$98.83M(+184.1%) |
| Jun 2020 | - | -$49.75M(-234.5%) | -$34.79M(-6.2%) |
| Mar 2020 | - | $37.00M(-258.6%) | -$37.09M(-67.4%) |
| Dec 2019 | -$113.81M(-28.3%) | -$23.32M(-1910.9%) | -$113.76M(-31.0%) |
| Sep 2019 | - | $1.29M(-102.5%) | -$164.76M(-7.9%) |
| Jun 2019 | - | -$52.05M(+31.2%) | -$178.93M(+8.3%) |
| Mar 2019 | - | -$39.67M(-46.6%) | -$165.22M(+3.6%) |
| Dec 2018 | -$158.65M(+17.4%) | -$74.32M(+476.6%) | -$159.41M(+12.5%) |
| Sep 2018 | - | -$12.89M(-66.4%) | -$141.69M(-2.3%) |
| Jun 2018 | - | -$38.34M(+13.2%) | -$145.01M(-1.1%) |
| Mar 2018 | - | -$33.86M(-40.2%) | -$146.57M(+8.5%) |
| Dec 2017 | -$135.15M(-49.5%) | -$56.60M(+249.2%) | -$135.15M(-19.7%) |
| Sep 2017 | - | -$16.21M(-59.4%) | -$168.30M(-20.8%) |
| Jun 2017 | - | -$39.90M(+77.8%) | -$212.44M(+6.2%) |
| Mar 2017 | - | -$22.44M(-75.0%) | -$200.06M(-24.7%) |
| Dec 2016 | -$267.82M(-17.0%) | -$89.76M(+48.7%) | -$265.62M(-8.1%) |
| Sep 2016 | - | -$60.35M(+119.4%) | -$288.90M(-8.1%) |
| Jun 2016 | - | -$27.51M(-68.7%) | -$314.33M(-7.7%) |
| Mar 2016 | - | -$88.00M(-22.1%) | -$340.43M(+5.2%) |
| Dec 2015 | -$322.58M(+96.0%) | -$113.03M(+31.8%) | -$323.69M(+20.1%) |
| Sep 2015 | - | -$85.78M(+60.0%) | -$269.41M(+10.9%) |
| Jun 2015 | - | -$53.61M(-24.8%) | -$242.87M(+18.3%) |
| Mar 2015 | - | -$71.26M(+21.3%) | -$205.37M(+27.3%) |
| Dec 2014 | -$164.62M(+18.8%) | -$58.76M(-0.8%) | -$161.27M(+9.1%) |
| Sep 2014 | - | -$59.24M(+267.7%) | -$147.76M(+14.4%) |
| Jun 2014 | - | -$16.11M(-40.7%) | -$129.21M(-5.1%) |
| Mar 2014 | - | -$27.15M(-40.0%) | -$136.09M(-1.2%) |
| Dec 2013 | -$138.59M(+38.8%) | -$45.25M(+11.2%) | -$137.70M(+6.9%) |
| Sep 2013 | - | -$40.69M(+77.0%) | -$128.79M(+29.9%) |
| Jun 2013 | - | -$23.00M(-20.1%) | -$99.18M(-10.2%) |
| Mar 2013 | - | -$28.77M(-20.8%) | -$110.41M(+5.8%) |
| Dec 2012 | -$99.86M(+214.7%) | -$36.34M(+227.9%) | -$104.38M(+53.4%) |
| Sep 2012 | - | -$11.08M(-67.6%) | -$68.04M(+19.5%) |
| Jun 2012 | - | -$34.23M(+50.6%) | -$56.96M(+147.7%) |
| Mar 2012 | - | -$22.73M(<-9900.0%) | -$22.99M(-754.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$31.73M(+666.4%) | $0.00(0.0%) | $3.52M(+2030.3%) |
| Sep 2011 | - | $0.00(-100.0%) | $165.00K(-112.4%) |
| Jun 2011 | - | -$262.00K(-106.9%) | -$1.33M(+24.6%) |
| Mar 2011 | - | $3.78M(-212.7%) | -$1.07M(-78.0%) |
| Dec 2010 | -$4.14M(-125.1%) | -$3.35M(+124.2%) | -$4.84M(+224.2%) |
| Sep 2010 | - | -$1.49M(<-9900.0%) | -$1.49M(<-9900.0%) |
| Jun 2010 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2010 | - | $0.00(0.0%) | $4.31M(-1597.6%) |
| Dec 2009 | $16.49M(-58.5%) | $0.00(0.0%) | -$288.00K(-100.9%) |
| Sep 2009 | - | $0.00(-100.0%) | $31.77M(-6.9%) |
| Jun 2009 | - | $4.31M(-193.7%) | $34.12M(-0.6%) |
| Mar 2009 | - | -$4.60M(-114.4%) | $34.34M(-13.6%) |
| Dec 2008 | $39.76M(-169.4%) | $32.06M(+1263.5%) | $39.76M(-2480.5%) |
| Sep 2008 | - | $2.35M(-48.1%) | -$1.67M(-92.2%) |
| Jun 2008 | - | $4.53M(+453.8%) | -$21.52M(-45.7%) |
| Mar 2008 | - | $818.00K(-108.7%) | -$39.65M(-30.8%) |
| Dec 2007 | -$57.29M(+30.4%) | -$9.37M(-46.5%) | -$57.29M(-12.1%) |
| Sep 2007 | - | -$17.50M(+28.7%) | -$65.15M(+14.7%) |
| Jun 2007 | - | -$13.60M(-19.1%) | -$56.82M(+15.2%) |
| Mar 2007 | - | -$16.82M(-2.4%) | -$49.30M(+12.2%) |
| Dec 2006 | -$43.95M(-42.2%) | -$17.23M(+87.8%) | -$43.95M(+3.1%) |
| Sep 2006 | - | -$9.18M(+50.9%) | -$42.61M(-14.8%) |
| Jun 2006 | - | -$6.08M(-46.9%) | -$50.00M(-24.2%) |
| Mar 2006 | - | -$11.46M(-27.9%) | -$65.99M(-13.2%) |
| Dec 2005 | -$76.05M(-0.8%) | -$15.90M(-4.0%) | -$76.05M(-0.5%) |
| Sep 2005 | - | -$16.56M(-25.0%) | -$76.45M(-8.0%) |
| Jun 2005 | - | -$22.08M(+2.6%) | -$83.11M(+6.9%) |
| Mar 2005 | - | -$21.52M(+32.0%) | -$77.73M(+5.3%) |
| Dec 2004 | -$76.69M(+10.8%) | -$16.30M(-29.8%) | -$73.79M(-10.7%) |
| Sep 2004 | - | -$23.21M(+39.0%) | -$82.60M(+3.2%) |
| Jun 2004 | - | -$16.70M(-5.0%) | -$80.06M(+0.6%) |
| Mar 2004 | - | -$17.58M(-30.0%) | -$79.55M(-3.6%) |
| Dec 2003 | -$69.21M(+26.6%) | -$25.11M(+21.5%) | -$82.52M(+13.2%) |
| Sep 2003 | - | -$20.67M(+27.7%) | -$72.91M(+8.4%) |
| Jun 2003 | - | -$16.19M(-21.2%) | -$67.28M(+5.0%) |
| Mar 2003 | - | -$20.54M(+32.5%) | -$64.07M(+12.6%) |
| Dec 2002 | -$54.68M(+35.7%) | -$15.50M(+3.0%) | -$56.88M(-10.4%) |
| Sep 2002 | - | -$15.05M(+16.0%) | -$63.49M(+9.2%) |
| Jun 2002 | - | -$12.97M(-2.8%) | -$58.12M(+4.1%) |
| Mar 2002 | - | -$13.35M(-39.6%) | -$55.81M(+8.3%) |
| Dec 2001 | -$40.30M(+22.1%) | -$22.12M(+128.7%) | -$51.52M(+85.7%) |
| Sep 2001 | - | -$9.67M(-9.3%) | -$27.74M(-2.5%) |
| Jun 2001 | - | -$10.67M(+17.8%) | -$28.45M(+13.9%) |
| Mar 2001 | - | -$9.06M(-645.3%) | -$24.97M(+6.5%) |
| Dec 2000 | -$33.00M(+20.0%) | $1.66M(-116.0%) | -$23.45M(-23.7%) |
| Sep 2000 | - | -$10.38M(+44.4%) | -$30.74M(+3.9%) |
| Jun 2000 | - | -$7.19M(-4.7%) | -$29.60M(-0.4%) |
| Mar 2000 | - | -$7.54M(+34.0%) | -$29.71M(+11.1%) |
| Dec 1999 | -$27.50M(+112.3%) | -$5.63M(-39.1%) | -$26.75M(+26.6%) |
| Sep 1999 | - | -$9.24M(+26.5%) | -$21.12M(+77.7%) |
| Jun 1999 | - | -$7.30M(+59.3%) | -$11.89M(+159.3%) |
| Mar 1999 | - | -$4.58M(<-9900.0%) | -$4.58M(<-9900.0%) |
| Dec 1998 | -$12.95M(+357.9%) | - | - |
| Dec 1998 | - | $0.00 | $0.00 |
| Dec 1997 | -$2.83M | - | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual EBIT year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly EBIT year-on-year change?
- What is BioMarin Pharmaceutical Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. TTM EBIT year-on-year change?
What is BioMarin Pharmaceutical Inc. annual earnings before interest & taxes?
The current annual EBIT of BMRN is $529.80M
What is the all time high annual EBIT for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual earnings before interest & taxes is $529.80M
What is BioMarin Pharmaceutical Inc. annual EBIT year-on-year change?
Over the past year, BMRN annual earnings before interest & taxes has changed by +$335.36M (+172.48%)
What is BioMarin Pharmaceutical Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of BMRN is $301.51M
What is the all time high quarterly EBIT for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly earnings before interest & taxes is $301.51M
What is BioMarin Pharmaceutical Inc. quarterly EBIT year-on-year change?
Over the past year, BMRN quarterly earnings before interest & taxes has changed by +$198.05M (+191.43%)
What is BioMarin Pharmaceutical Inc. TTM earnings before interest & taxes?
The current TTM EBIT of BMRN is $824.59M
What is the all time high TTM EBIT for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high TTM earnings before interest & taxes is $824.59M
What is BioMarin Pharmaceutical Inc. TTM EBIT year-on-year change?
Over the past year, BMRN TTM earnings before interest & taxes has changed by +$565.05M (+217.72%)